Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I realize whenever I do chime in it generally comes as a pessimistic take.
But the more that I see the news that comes out about these various "plans" the more I feel that my thoughts are validated.
The FDA and Pfff...fizer have been playing with the rubber ducky in the tub for quite some time, What we're seeing with the FDA setting this up with Pfizer is nothing more than taking the soap and wash cloth below the water for Pfizer.
What should have happened? Pfizer's credibility should have been destroyed the minute they could verify faulty testing with the Paxlovid rebounds in vaccinated people. If not from the false data provided or hidden for the vaccine trials.
In the meantime, we wait. Part due to RVVTF, but I believe in large part due to kick backs and politics.
HAHAHAHA!
Same here! I don't have as many shares as some, but more than most. Thinking about trying to get my holdings up to a nice round number of about 100k. That would be nice.
Great selection. My favorite artist. Timely message.
Let's hope it comes to fruition.
That settles it! Looks like RVV will be behind the red-tape line for about 6-8 months regarding any type of funding help.
That should be just enough time for Pppp-fizer to get their therapeutic pill close enough to the finish line to have the FDA push them to the front of line for priority.
Honestly, that sounds like the symptoms I remembered going through when I was going through a cold. I haven't had a cold in over 4 years, but now those same symptoms would be earmarked as COVID.
Notice that the article is careful not to name names?
I think overall we have reason to be offended at just how little common sense was used throughout this time. Everything that has been done to this point has been through greed.
Now that the real money has cleared the table, they may make room for the smaller players and the things that actually would have helped through all of this.
Serious question. Not an attempt to be snarky or creating "gotcha" opportunities.
Do you sincerely believe that it is just because of a lack of data that Revive hasn't gotten any run with their therapeutics? I realize their testing has been sparse, but if the WHO, CDC, NIH, and others (The Sciences) were truly interested in seeing these types of things get to market, they would turn every stone. This includes funding to make sure clinical/trial testing is robust enough to obtain the needed sample size.
What we have instead, is a drug maker who get to push through, whatever they call good, at will. At the point where efficacy was learned to be diminishing, that "vaccine" should have been flagged and any subsequent "vaccines or boosters" should have been scrutinized much more heavily than they were
What we also have is a therapeutic (Monoclonal anti-bodies) that have been widely used, and have an enormous success rate, suddenly taken over and the distribution of it being scrutinized. What happens now with that one is it will be given to someone who is really in need and is well connected.
Meanwhile, the therapeutics that are most effective between day-1 and day-5 of infection, are only being administered after an individual is admitted to the hospital and likely past day-10.
This information should be so damning. Coupled with the increasing reports of fully vaccinated and boosted individuals still getting the virus (AND surpassing unvaccinated in hospitalizations). You would think the focus would be turned to other potential vaccines and particularly therapeutics. Yet, here we are.
Yes! That expectation is entirely ridiculous!
There is absolutely NO WAY that bus can maneuver properly in order to get into the space as that mock-up suggests.
We should talk to the Civil Engineer/Planner responsible for this rendering...
Yes, agreed.
To lay something at the feet of Revive though. You would think they would have gone above and beyond on their test data and gone well over 1000 test subjects by now.
But that doesn't keep the FDA from doing what they should be doing, and looking at ALL avenues and alternatives. But we know that they are feigning like they are, but really just bedding the big-pharma companies.
I think the FDA is still just sitting on the data, then just rubbing their proverbial "chin". You know that one where you expect them to come back and tell you something bad. But deep down you know it's good, and truthfully they do too, but they're trying to find a reason to pin you in place for just a little longer.
I guess the next question is, did anyone with a US based account receive the correct allotment based on the 1 share for every 8 shares of mnxxf owned?
I have not asked yet. will try to reach out to them to pose the question.
Did you receive the 1 for 8 allotment that was originally announced? I received shares, but it was about a 7th of that.
Generally, what happens with Caveat Emptor or Limited/No Report is that the stock can still be sold, but most investment institutions will not allow anyone to buy that ticker on their platform. That may be the case with the ticker you mention.
The article that you referenced is not available through the link or using the article number on the home page.
I won't say suspicious (on their part), but it certainly seems interesting that these types of important articles and facts are hanging around for long.
I would add that Pfizer's product could be subject to scrutiny into its use, as how is it possible that they have thoroughly tested the product? This is the same for their initial vaccine.
They are a large conglomerate so they can pay to play. But what happens when the product turns out to not be as good as advertised because it was rushed through the process, or some critical information was allowed to be brushed under the rug?
Revive, partly through its own doing, has had to slog through the process. But what we will know coming out of them getting through the process is that it was throughly tested and scrutinized.
I appreciate the response and the viewpoint, my railings were not as much against Revive being stuck behind the 8-ball, but the prioritization of therapeutics (or what could heal those already infected).
Life was basically put on hold, and it seemed the only focus was on a vaccine, which they couldn't guarantee at that point.
With all the therapeutics that were put forward, think about the fallout or responses that were being given as to why they wouldn't work. I don't fully know how dismissive the decision making entities were in all of it, but it is clear that was the case, as it remains the case even now.
Here today we sit inundated with public service announcements about the vaccines effectiveness, and yet just a week ago we hear of the death of an "iconic" figure in Colin Powell who died from "complications due to COVID", in what was admitted to be a breakthrough case. The vaccine is still a reach, and they haven't yet made a half-hearted effort to reach for effective therapeutics.
But you must admit, the politics of all of this is amazing.
If the true interest in this was to find a way to actually help & protect the people around the world we can look at a few things:
1) The first thing that absolutely SHOULD have been addressed is therapeutics. Why? Because people were already getting sick and dying from COVID. Logic says you address the biggest ailment in the situation. What good is putting all research on hold for a vaccine if we don't know that it will eradicate the problem? As we have all seen, none of the current vaccines eradicate the virus, they only suppress symptoms. They don't even protect people from getting it again. That is NOT a vaccine. But we all know that here.
2) With regards to the therapeutics, all options should have been on the table IMMEDIATELY! For companies that believed they had a viable solution, it should have been tested, evaluated, and screened out based on performance. If a company was too small to be able to afford to administer full testing, this is where the FDA and the government should have interceded and assisted with financing to push "good products" forward.
But all of this is IF they were truly concerned with and looking out for the sake of the people.
As nice as that would be, to see a generous donation come in to fund the distribution of Bucillamine, I feel like that is a "one-time" thing from the Gates Foundation. I would love to be wrong, but these folks have their partnerships and inside handshakes.
I mean, how long have we known this product is resting on the cusp of approval, and what it is capable of doing for the public? Yet, the time for investors and philanthropists to step forward was several months ago for this company.
We saw the writing on the wall when Merck even announced back in April or May that they were "hoping" to finish a pill and seek EAU. At that time it was even suggested that they would be rushed to the finish line while Revive is left to slog through the mire and do it the hard way.
I can't say that I am sickened by it, I won't say "I told you so", but we can see the writing on the wall. Bill Gates is into "king making" and "picking winners". I hope I will be proved wrong, but we can see a continuing pattern of operation/behavior.
Thanks for sharing the link. That is a great interview, with lots of good insights. Hopefully we see this come to fruition soon.
What seems awkward to you about that? It falls along the path that they've openly stated that they would follow.
They feel they have developed replacement OER and HER catalysts, they said they would be building a prototype Hydrolyzer. Now they are saying that they will continue to seek ("explore") additional improvements on the catalysts.
Not sure why that would be laughable. But we gots-ta-do what we gots-ta-do.
It's not about the "balls to say names", and you know it!
It is about keeping the post neutral, otherwise the post is magically declared "off-topic".
For the others, do your research, trust your instincts. The issues and intentional foul-play that was mentioned very well could have been true with a few of those companies. But as you already know, some of these companies are small research and development types. So when they're attacked for jumping from product to product or for changing names, they are sometimes forced down that path thanks to other circumstances beyond their control.
Or, cjspierman, you can dig into that information and see what a few of the companies did to separate themselves from that group of investors.
That information is predicated on a few individuals who were doing bad things, or had been known to have been involved in unethical practices.
What he won't show you is that some of the companies moved on from them after the very short period of time that they worked with them. BioSolar (now NewHydrogen) was one of those companies. They borrowed money from one of the people who was involved in shady lending practices. They have since settled that toxic debt/loan and they are finally again settled trying to work on their technology.
But what that information (and the bearer of it) would have you believe is that it is a continual action and they are regularly participating in deceptive practices and regularly taking toxic loans.
I sifted through all of the information provided and whittled it down to a few of the companies that were absolutely not doing right, but not all of them as that list would have you believe. Research for yourself, and don't let your opinions be swayed just because the claims are that one apple spoiled the whole bunch.
That pill reportedly treats an individual that already has COVID, and cuts their chances of death "in half".
Vaxart needs to just keep plugging away, because they could possibly have the key to a true vaccine. Everything else so far seems to be just a treatment.
This is not true.
E-Trade, along with other platforms, will not allow new purchases of OTC stocks that are "Pink - Not Current" or "Caveat Emptor". As long as the company trading on the OTC platform is current with their information, you will be able to buy and sell that ticker.
If they are identified as "Not Current" or "Caveat Emptor" you will be able to sell your positions in that ticker, but you will not be able to buy them.
Fair assessment, when the process is by the rules or the way it should be.
However, with that same information in mind, would you say that Pfizer has been held to the same standard?
I get that they really wanted the "vaccine" made available as quickly as possible. But seriously, do you believe Pfizer will be held to the same standard of testing? Will they be relegated to only being able to test their COVID therapeutic pill to those who have tested positive within 48 hours?
I am not disputing that Revive is having to follow the right and reasonable test matrix. Which BTW I whole-heartedly agree that they should.
But what I am saying is that it seems the goalposts are being moved in a game where we knew who the powerhouses were to begin with. Especially when therapeutics should have been the first thing they needed, AND with medications that have already been in use for other things for years/decades.
I don't mean to sound like a naysayer, but I firmly believe suppression is in full force.
For as much as we've seen this process get dragged severely for Revive, I can't help but think that the FDA is intentionally sitting on them.
I am holding heavy and long, not as heavy as many here but heavy enough that it easily will be life changing for me if/once they receive FDA approval. But something tells me that a game is being played with therapeutics, as we have seen evidence with HCQ and Ivermectin. This ones saving grace is that it was tucked behind the guise of FDA approval.
While I certainly hope I am wrong, and we see approval soon. We already have evidence that something is afoul, as therapeutics should have been prioritized very heavily from the very beginning. But we see how that continues to work out.
I agree, this was a fastball in slow motion. We could see this one coming a long time ago.
This is good news. But I had to re-read this to fully understand.
The terminology "Exclusive Worldwide License Agreement" always sounds amazing on the surface.
However, what they have done is basically obtained the Intellectual Property from PRSTRT and St. Jude. Further to this though is that a patent application has already been submitted.
This is another item they can stair-step to human trials. But this is not yet a promise of a sale, distribution, or otherwise.
"Revive, PRSTRT and St. Jude agreed to terms consistent with industry standards, including future payments based on clinical trial and revenue milestones."
One step closer on another item, but I will still be growing and holding.
This is why we can't have nothin' nice:
https://finance.yahoo.com/news/moderna-receives-fda-fast-track-131000215.html
I see that they are also working on a Phase 1 therapeutic. Wanna guess if they will file to have that fast-tracked too?
Kinda hard to achieve anything in the game, if the game is rigged.
That's fine, but the article is actually not theirs.
At the bottom of the article you will see a [source] link which takes you to the InfoWars page. For some, that is 6 in one hand, half dozen in the other, but InfoWars isn't The Enquirer.
I would imagine there are quite a few more re-infected fatalities, but that is news that is not wanted out. The power that currently be would rather push the requirement to receive the vaccine consequences be damned.
Oh my! The travesty!
Ferroglobe has more than one partner. EGADs!!!
...if we could only figure out a name to call those conspiracy theories once they've been determined to be true...
...any suggestions?!?
I don't believe the PR amounts to nothing, but I do agree that the more time taken to get clearance, the less the market value &for this opportunity. But we already know that.
The real question is "why?"
It is still my contention that the king makers have ultimate sway in the requirements. Just as the DSMB is requiring the 600 MG testing, what are they not satisfied with by this point in time?
It seems to me that Revive has had such stringent requirements placed in front of them to make sure they test properly, I would wonder if the others will be even close to this tight on testing.
At this point it seems that a good & effective therapeutic is not even the concern of the DSMB and the FDA.
By this time it either works or it doesn't, the concern should not be as much about safety for a medication that has been on the market for decades.
Hmmm! Hardly seems fair that you are lobbing claims of malfeasance, and you have this beautiful word tree to support your claims. But like I said, I offered you information that you and I could go through together and debate (if you’d like), but you said (and still are saying) “no!”
The basis of your information is rooted in the idea that they are dealing with a “crooked accountant”, so to speak. So, naturally if the accountant is crooked they must be crooked.
Your claim also includes that there is a shared mailing address, and that two of the companies filed an 8-k with that same address.
My theories or potential rebuttals have been posed. But rather than acknowledge the theories or even counter, you simply say, “I don’t care what you show me”. Sounds objective to me.
There may have been a way they did things to stay afloat with the convertible loans, but there was a legitimate transaction that happened at the beginning of this year that took care of ALL of those toxic convertibles. Don’t take my word for it, you can read it for yourself in their most recent 10-q.
While they severed their relationship with Soelect (just one of the partnerships they had on the battery front), we haven’t gotten that message for the other two (TopBattery & Ferroglobe). Until I see an official announcement saying those two partnerships are severed, I can really only continue on with the thought that they are still in play. Can you prove otherwise?
Lastly, they hired a COO, legitimately! Fa-REELZ!!! Even put out an 8-k and Form-4’s to prove it. Oh! That’s right!! Those can’t be believed because that can’t trump your belief that he is part of the scam. Not a real person maybe?!? Nah! That’s not it! I know, if it were true then that is another domino that can no longer be used to scare potential new investors away.
Maybe I am on to something…
If that is the case, you should have no problem presenting the facts that you have that state they are not a legit company.
I know what it was that I was presented, but I remember when I started to refute those claims with some other findings and ask you questions about the information, my posts started to disappear AND I was told you had no interest in hearing what I was presenting.
Is this just a one way street, as far as who can present "credible information"? That is, basically to say that my information that is presented cannot be considered as valid?!?
I am going off of press releases, 8-k's, and 10-k/q's. Didn't know that I shouldn't believe in those anymore...
Yes!
They're also trying to push Pfizers idea of a "3rd shot" or "booster" or basically a therapeutic through the system.
I bet if Pfizer can get their act together on that within the next two month you will hear all about it, and Revive stays off the stove, let alone making it to a back burner.
Agreed! My shares will graduate to long-term investments in about 2 weeks.
I remember seeing several folks mentioning they had hundreds of thousands of shares. I am not that fortunate. But, if this thing sees $30 p/share, I will be a very happy, changed life man.
No, not mad.
What I generally see is laughing and mocking coming from folks that dissent. I'm really more wanting to defend and keep others from being discouraged from buying.
After all, I feel I have reasonable evidence to show that NewHydrogen is legit in what they're doing. But I know there are other(s) that seem put off by it, so they propagate information that alleges wrongdoing, or purposeful misgivings.
YET, when the information contrary to those claims is offered, it seems other(s) would rather run from it. Which tells me that I am not "pumping", but they are just "dumping".
So, I won't be chased out. I am here to be an ambassador, even if others want to antagonize and discourage and gang up on investors just wanting to have good constructive conversation. Even if the stock is not prospering.